Home/Filings/4/0001491877-10-000007
4//SEC Filing

DAVIS PETER B 4

Accession 0001491877-10-000007

CIK 0000072444other

Filed

May 23, 8:00 PM ET

Accepted

May 24, 8:31 PM ET

Size

7.6 KB

Accession

0001491877-10-000007

Insider Transaction Report

Form 4
Period: 2010-05-20
Transactions
  • Purchase

    Common Stock

    2010-05-20$5.24/sh+3,816$19,99614,630 total
  • Award

    Stock Option (right to buy)

    2010-05-20+20,00020,000 total
    Exercise: $5.24Exp: 2017-05-20Common Stock (20,000 underlying)
Footnotes (2)
  • [F1]The purchase reported in this form was made upon election of director to receive his entire annual director fee retainer in common stock pursuant to Section 14 of the 2007 Omnibus Equity and Incentive Plan.
  • [F2]The Stock Option (right to buy) is exercisable in four equal installments on August 20, 2010, November 20, 2010, February 20, 2011, and May 20, 2011.

Issuer

NABI BIOPHARMACEUTICALS

CIK 0000072444

Entity typeother

Related Parties

1
  • filerCIK 0001222789

Filing Metadata

Form type
4
Filed
May 23, 8:00 PM ET
Accepted
May 24, 8:31 PM ET
Size
7.6 KB